A Phase I Clinical Study, Randomized, Single-blind, Placebo-controlled, Multiple Doses, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects.

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Alzheimer Disease
Interventions
DRUG

Donepezil

DRUG

placebo

Trial Locations (1)

138-736

ASAN Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Icure Pharmaceutical Inc.

INDUSTRY

NCT02178124 - A Phase I Clinical Study, Randomized, Single-blind, Placebo-controlled, Multiple Doses, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects. | Biotech Hunter | Biotech Hunter